A refractory MLL-FP degradation in MLL-r ALL may therefore lead to sustained telomere transcription, and the analysis of synchronized MLL-r ALL cells will be required to confirm elevated levels of TERRA throughout the cell cycle. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.